GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹7,527 Cr | ₹6,783 Cr | ₹5,645 Cr | ₹6,901 Cr | ₹5,852 Cr |
What is the latest Total Current Assets ratio of GLAND PHARMA ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹7,527 Cr |
| Mar2025 | ₹6,783 Cr |
| Mar2024 | ₹5,645 Cr |
| Mar2023 | ₹6,901 Cr |
| Mar2022 | ₹5,852 Cr |
How is Total Current Assets of GLAND PHARMA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,527 Cr | 10.97 | |
| Mar2025 | ₹6,783 Cr | 20.16 | |
| Mar2024 | ₹5,645 Cr | -18.20 | |
| Mar2023 | ₹6,901 Cr | 17.92 | |
| Mar2022 | ₹5,852 Cr | - | |
Compare Total Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,384.6 Cr | -0.3% | 11% | 52% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.3% |
11% |
52% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses